161 related articles for article (PubMed ID: 38460727)
1. Increased PD-1 Expression on Circulating T Cells Correlates with Inferior Outcome after Autologous Stem Cell Transplantation.
Richter S; Böttcher M; Stoll A; Zeremski V; Völkl S; Mackensen A; Ekici AB; Jacobs B; Mougiakakos D
Transplant Cell Ther; 2024 Jun; 30(6):628.e1-628.e9. PubMed ID: 38460727
[TBL] [Abstract][Full Text] [Related]
2. Impact of Risk Factors and Long Term Survival Analysis of Patients With Primary Refractory Hodgkin Lymphoma Who Underwent High Dose Chemotherapy and Autologous Stem Cell Transplant.
Akhtar S; Rauf MS; Elhassan TAM; Khan ZA; Elshenawy MA; Maghfoor I
Transplant Cell Ther; 2023 Jul; 29(7):451.e1-451.e12. PubMed ID: 37031748
[TBL] [Abstract][Full Text] [Related]
3. The metabolic profile of reconstituting T-cells, NK-cells, and monocytes following autologous stem cell transplantation and its impact on outcome.
Richter S; Böttcher M; Völkl S; Mackensen A; Ullrich E; Jacobs B; Mougiakakos D
Sci Rep; 2022 Jul; 12(1):11406. PubMed ID: 35794135
[TBL] [Abstract][Full Text] [Related]
4. Highly proliferative and functional PD-1
Batorov EV; Aristova TA; Pronkina NV; Sergeevicheva VV; Sizikova SA; Ushakova GY; Shevela EY; Ostanin AA; Chernykh ER
Int Immunopharmacol; 2021 Nov; 100():108093. PubMed ID: 34474273
[TBL] [Abstract][Full Text] [Related]
5. Effect of transplanted cells with CD184 and CD26 expressions and reconstitution of CD3+ lymphocyte population on long-term survival after autologous hematopoietic stem cell transplantation for multiple myeloma.
Kopinska A; Krawczyk-Kulis M; Wieczorkiewicz-Kabut A; Koclega A; Jagoda K; Dziaczkowska-Suszek J; Helbig G
Exp Hematol; 2023 Nov; 127():52-58.e1. PubMed ID: 37666354
[TBL] [Abstract][Full Text] [Related]
6. Immune Reconstitution following High-Dose Chemotherapy and Autologous Stem Cell Transplantation with or without Pembrolizumab Maintenance Therapy in Patients with Lymphoma.
Merryman RW; Redd R; Jeter E; Wong JL; McHugh K; Reynolds C; Nazzaro M; Varden A; Brown JR; Crombie JL; Davids MS; Fisher DC; Jacobsen E; Jacobson CA; Kim AI; LaCasce AS; Ng SY; Odejide OO; Parry EM; Dahi PB; Nieto Y; Joyce RM; Chen YB; Herrera AF; Armand P; Ritz J
Transplant Cell Ther; 2022 Jan; 28(1):32.e1-32.e10. PubMed ID: 34670169
[TBL] [Abstract][Full Text] [Related]
7. Autologous Hematopoietic Stem Cell Transplantation for Patients with Lymphoma-Associated Hemophagocytic lymphohistiocytosis.
Song Y; Yin Q; Wang J; Wang Z
Cell Transplant; 2021; 30():9636897211057077. PubMed ID: 34743574
[TBL] [Abstract][Full Text] [Related]
8. Autologous followed by allogeneic versus tandem-autologous transplantation in high-risk, newly diagnosed multiple myeloma: a systematic review and meta-analysis.
Wei M; Xie C; Huang J; Liu Q; Lai Y
Hematology; 2023 Dec; 28(1):2269509. PubMed ID: 37850613
[TBL] [Abstract][Full Text] [Related]
9. Autologous stem cell transplantation in multiple myeloma patients over 70 years: A GIMEMA Lazio Working Group experience in a retrospective case-control study.
Rago A; Annibali O; Tomarchio V; Coppetelli U; Fazio F; Cupelli L; Fiorini A; Piciocchi A; Tafuri A; Caravita di Toritto T
Eur J Haematol; 2022 Sep; 109(3):250-256. PubMed ID: 35617025
[TBL] [Abstract][Full Text] [Related]
10. Outpatient reduced-intensity allogeneic stem cell transplantation for patients with refractory or relapsed lymphomas compared with autologous stem cell transplantation using a simplified method.
Gutiérrez-Aguirre CH; Ruiz-Argüelles G; Cantú-Rodríguez OG; González-Llano O; Jaime-Pérez JC; García-Rodríguez F; López-Otero A; Herrera-Garza JL; Gómez-Almaguer D
Ann Hematol; 2010 Oct; 89(10):1045-52. PubMed ID: 20490794
[TBL] [Abstract][Full Text] [Related]
11. Nitrosourea, etoposide and cyclophosphamide followed by autologous stem cell transplantation for pediatric lymphoma patients.
Choi JY; Kang HJ; An HY; Hong KT; Shin HY
Int J Hematol; 2020 Jun; 111(6):877-887. PubMed ID: 32215821
[TBL] [Abstract][Full Text] [Related]
12. CMV Triplex Vaccine to Enhance Adaptive NK and T-cell Reconstitution After Autologous Hematopoietic Cell Transplantation.
Rashidi A; La Rosa C; Curtsinger J; Cao Q; Zhou Q; Lingaraju CR; Weisdorf DJ; Cichocki F; Miller JS; Diamond DJ
Transplant Cell Ther; 2022 Jun; 28(6):343.e1-343.e4. PubMed ID: 35272066
[TBL] [Abstract][Full Text] [Related]
13. Impact of Radiation Therapy After High Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation in Patients With Relapsed/Refractory Lymphomas: A Single Center Experience.
Osmani AH; Khafaga Y; Rauf MS; Maghfoor I; Akhtar S
Clin Lymphoma Myeloma Leuk; 2022 Mar; 22(3):e149-e160. PubMed ID: 34627735
[TBL] [Abstract][Full Text] [Related]
14. Myeloma escape after stem cell transplantation is a consequence of T-cell exhaustion and is prevented by TIGIT blockade.
Minnie SA; Kuns RD; Gartlan KH; Zhang P; Wilkinson AN; Samson L; Guillerey C; Engwerda C; MacDonald KPA; Smyth MJ; Markey KA; Vuckovic S; Hill GR
Blood; 2018 Oct; 132(16):1675-1688. PubMed ID: 30154111
[TBL] [Abstract][Full Text] [Related]
15. Autograft cellular composition and outcome in myeloma patients: Results of the prospective multicenter GOA study.
Turunen A; Silvennoinen R; Partanen A; Valtola J; Siitonen T; Putkonen M; Sankelo M; Pyörälä M; Kuittinen T; Penttilä K; Sikiö A; Savolainen ER; Mäntymaa P; Pelkonen J; Varmavuo V; Jantunen E
Transfusion; 2021 Jun; 61(6):1830-1844. PubMed ID: 33955591
[TBL] [Abstract][Full Text] [Related]
16. A Japanese single-hospital observational trial with a retrospective case-control analysis of varicella zoster virus reactivation after autologous peripheral blood stem cell transplantation.
Mawatari M; Isoda A; Miyazawa Y; Sawamura M; Matsumoto M
Transpl Infect Dis; 2015 Aug; 17(4):544-50. PubMed ID: 26041667
[TBL] [Abstract][Full Text] [Related]
17. Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation.
Baek DW; Moon JH; Lee JH; Kang KW; Lee HS; Eom HS; Lee E; Lee JH; Lee JO; Park SK; Kim SJ; Yoo KH; Yoon SS; Koh Y; Kang HJ; Won JH; Lyu CJ; Hahn SM; Lee JH; Park JS; Jo JC; Mun YC; Yang DH; Song GY; Lim SN; Sohn SK;
Blood Cancer J; 2023 Jun; 13(1):95. PubMed ID: 37365207
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with multiple myeloma.
El-Cheikh J; Crocchiolo R; Furst S; Stoppa AM; Ladaique P; Faucher C; Calmels B; Lemarie C; De Colella JM; Granata A; Coso D; Bouabdallah R; Chabannon C; Blaise D
Am J Hematol; 2013 May; 88(5):370-4. PubMed ID: 23460414
[TBL] [Abstract][Full Text] [Related]
19. CD4+ T Cell Dependent B Cell Recovery and Function After Autologous Hematopoietic Stem Cell Transplantation.
Heck C; Steiner S; Kaebisch EM; Frentsch M; Wittenbecher F; Scheibenbogen C; Hanitsch LG; Nogai A; le Coutre P; Bullinger L; Blau IW; Na IK
Front Immunol; 2021; 12():736137. PubMed ID: 34659226
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
